Global Pet Pharmaceuticals Market Growth 2021-2026
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pet Pharmaceuticals Consumption 2016-2026
3 Global Pet Pharmaceuticals by Company
- 3.1 Global Pet Pharmaceuticals Sales Market Share by Company
- 3.1.1 Global Pet Pharmaceuticals Sales by Company (2019-2021)
4 Pet Pharmaceuticals by Region
- 4.1 Global Pet Pharmaceuticals by Region
- 4.1.1 Global Pet Pharmaceuticals Sales by Region
5 Americas
- 5.1 Americas Pet Pharmaceuticals Sales by Country
- 5.1.1 Americas Pet Pharmaceuticals Sales by Country (2016-2021)
6 APAC
- 6.1 APAC Pet Pharmaceuticals Sales by Region
- 6.1.1 APAC Pet Pharmaceuticals Sales by Region (2016-2021)
7 Europe
- 7.1 Europe Pet Pharmaceuticals by Country
- 7.1.1 Europe Pet Pharmaceuticals Sales by Country (2016-2021)
8 Middle East & Africa
- 8.1 Middle East & Africa Pet Pharmaceuticals by Country
- 8.1.1 Middle East & Africa Pet Pharmaceuticals Sales by Country (2016-2021)
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
11 Global Pet Pharmaceuticals Market Forecast
- 11.1 Global Pet Pharmaceuticals Forecast by Region
- 11.1.1 Global Pet Pharmaceuticals Forecast by Regions (2021-2026)
12 Key Players Analysis
- 12.1 Zoetis
- 12.1.1 Zoetis Company Information
13 Research Findings and Conclusion
According to this latest study, the 2021 growth of Pet Pharmaceuticals will have significant change from previous year. By the most conservative estimates of global Pet Pharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 13110 million in 2020. Over the next five years the Pet Pharmaceuticals market will register a 7.3% CAGR in terms of revenue, the global market size will reach US$ 17380 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Antiparasitic
Biological Products
Antibacterial
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Prevention
Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC